scholarly journals Early and long-term outcome of aortic valve replacement with homograft versus mechanical prosthesis-8-year follow-up study

1997 ◽  
Vol 20 (10) ◽  
pp. 843-848 ◽  
Author(s):  
Tomasz Waszyrowski ◽  
JarosłAW D. Kasprzak ◽  
Maria Krzemi Ńska-Pakuła ◽  
Antoni Dziatkowiak ◽  
Janusz ZasLonka
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Mechanical Prosthesis ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Follow Up Study

Abstract 1565: Characterization and Outcome of Patients with Severe Symptomatic Aortic Stenosis Referred for Percutaneous Aortic Valve Replacement

Circulation ◽  
2007 ◽  
Vol 116 (suppl_16) ◽  
Author(s):  
Samir R Kapadia ◽  
Lars Svensson ◽  
Sachin Goel ◽  
Lee Wallace ◽  
Leonardo Rodriguez ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Stenosis ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Medical Management ◽  
Term Outcome ◽  
Long Term Outcome ◽  
All Cause Mortality

Introduction: Although severe symptomatic aortic stenosis (AS) is associated with poor long-term outcome without aortic valve replacement (AVR), many patients are considered high risk for AVR surgery. These patients are typically not referred to cardiac surgery and therefore remain ill defined. Many of these patients are now referred for possible percutaneous AVR (percAVR). We report the clinical and echocardiographic characteristics of these patients with their outcome. Methods: All patients screened for percAVR between 2/06 to 3/07 were studied. Clinical and echocardiographic characteristics of patients undergoing surgical AVR (sAVR), percAVR, balloon aortic valvuloplasty (BAV) and medical management were compared. Clinical follow-up was performed for all cause mortality. Patients that were bridged to sAVR or percAVR after BAV were included in the respective groups. Results: We screened 92 pts for consideration of percAVR at our institution in 1 year. Of these, 19 pts underwent surgical AVR, 18 patients percAVR and 36 patients had medical management without BAV. BAV was performed in 30 patients of which 8 pts underwent percAVR and 3 had sAVR. Most common reasons for medical management included death while being screened (n=10, 28%), patient not interested in the study (n=10, 28%) and questionable severity of symptoms or AS (n=9, 25%). BAV was used in patients that could not wait for percAVR to become available with an intention to bridge. This could not be accomplished in 9 (45%) pts due to death while waiting for percAVR, 4 (20%) pts doing well after BAV not wanting percAVR, and the remaining 6 (30%) pts with exclusion from the current percAVR protocol (e.g. age, bleeding, infection, etc). Conclusion: Symptomatic patients with severe AS have high mortality if AVR is not feasible in a timely manner. About one fifth of the patients referred for percAVR could undergo sAVR with good outcome. Patients managed medically or with BAV alone have unfavorable outcomes. Characteristics and Outcome of Screened Patients

Long-Term Outcome and Quality of Life After Biological Aortic Valve Replacement in Nonelderly Adults

2021 ◽  
Vol 111 (1) ◽  
pp. 142-149 ◽  
Author(s):  
Johannes Petersen ◽  
Henry Krogmann ◽  
Hermann Reichenspurner ◽  
Evaldas Girdauskas
Keyword(s):  
Quality Of Life ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Term Outcome ◽  
Long Term Outcome

scholarly journals STATINS USE AND LONG TERM OUTCOME POST SURGICAL AORTIC VALVE REPLACEMENT

2017 ◽  
Vol 69 (11) ◽  
pp. 1979
Author(s):  
Amer Hawatmeh ◽  
Mohammad Thawabi ◽  
Ahmad Abuarqoub ◽  
Ibrahim Khaddash ◽  
Sarah Studyvin ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Surgical Aortic Valve Replacement ◽  
Term Outcome ◽  
Long Term Outcome
Sign in / Sign up

Export Citation Format

Share Document